Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis

Oncogene volume 31, pages 3516–3524 (2012)Cite this article

Subjects

Abstract

Overexpression of the ErbB2 receptor tyrosine kinase in breast cancer contributes to tumor development and is associated with poor prognosis. However, the mechanism by which ErbB2 might contribute to metastasis is not well defined. To identify genes that mediate ErbB2-driven cell motility, we performed differential gene expression analysis of ErbB2-expressing migrating breast cancer cells vs mutant ErbB2-expressing non-migrating cells. Among the genes that were specifically induced in migrating cells were known transcriptional targets of ErbB2, such as matrix metalloproteinases, and novel ErbB2 targets. Contribution of selected candidate genes to ErbB2-driven cell motility was tested by small interfering RNA targeting. Knockdown of the soluble form of ST2 (sST2), also called interleukin-1 receptor-like 1, one of the most robustly induced genes, decreased ErbB2-induced cell motility in two different cell lines. In response to ErbB2 activation, sST2 protein expression and secretion were increased. Moreover, recombinant sST2 associated with the plasma membrane and sST2-blocking antibodies reduced ErbB2-induced motility. Interestingly, cells from metastatic breast tumors secreted higher levels of sST2 than primary tumor cells. Finally, sST2 was found at high levels in the serum of metastatic breast cancer patients. Our data suggest that sST2 contributes to breast cancer cell motility and that sST2 secretion is associated with metastasis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Benlimame N, He Q, Jie S, Xiao D, Xu YJ, Loignon M et al. (2005). FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. J Cell Biol 171: 505–516.

    Article  CAS  Google Scholar 

  • Bergers G, Reikerstorfer A, Braselmann S, Graninger P, Busslinger M . (1994). Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 13: 1176–1188.

    Article  CAS  Google Scholar 

  • Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D et al. (2006). Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353–357.

    Article  CAS  Google Scholar 

  • Bosc DG, Goueli BS, Janknecht R . (2001). HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 20: 6215–6224.

    Article  CAS  Google Scholar 

  • Brunner M, Krenn C, Roth G, Moser B, Dworschak M, Jensen-Jarolim E et al. (2004). Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med 30: 1468–1473.

    Article  Google Scholar 

  • Caruso R, Pallone F, Fina D, Gioia V, Peluso I, Caprioli F et al. (2006). Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. Am J Pathol 169: 268–278.

    Article  CAS  Google Scholar 

  • Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adelaide J, Cervera N et al. (2006). Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25: 2273–2284.

    Article  CAS  Google Scholar 

  • Dankort D, Maslikowski B, Warner N, Kanno N, Kim H, Wang Z et al. (2001). Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol Cell Biol 21: 1540–1551.

    Article  CAS  Google Scholar 

  • Dufour A, Sampson NS, Zucker S, Cao J . (2008). Role of the hemopexin domain of matrix metalloproteinases in cell migration. J Cell Physiol 217: 643–651.

    Article  CAS  Google Scholar 

  • Eisen MB, Spellman PT, Brown PO, Botstein D . (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863–14868.

    Article  CAS  Google Scholar 

  • Fabre S, Reymond N, Cocchi F, Menotti L, Dubreuil P, Campadelli-Fiume G et al. (2002). Prominent role of the Ig-like V domain in trans-interactions of nectins. Nectin3 and nectin 4 bind to the predicted C-C’-C’-D beta-strands of the nectin1V domain. J Biol Chem 277: 27006–27013.

    Article  CAS  Google Scholar 

  • Gayle MA, Slack JL, Bonnert TP, Renshaw BR, Sonoda G, Taguchi T et al. (1996). Cloning of a putative ligand for the T1/ST2 receptor. J Biol Chem 271: 5784–5789.

    Article  CAS  Google Scholar 

  • Grossmann KS, Wende H, Paul FE, Cheret C, Garratt AN, Zurborg S et al. (2009). The tyrosine phosphatase Shp2 (PTPN11) directs neuregulin-1/ErbB signaling throughout Schwann cell development. Proc Natl Acad Sci USA 106: 16704–16709.

    Article  CAS  Google Scholar 

  • Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ . (1992). Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578–10582.

    Article  CAS  Google Scholar 

  • Hayakawa H, Hayakawa M, Kume A, Tominaga S . (2007). Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282: 26369–26380.

    Article  CAS  Google Scholar 

  • Hijazi MM, Thompson EW, Tang C, Coopman P, Torri JA, Yang D et al. (2000). Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines. Int J Oncol 17: 629–641.

    CAS  PubMed  Google Scholar 

  • Ho IA, Chan KY, Ng WH, Guo CM, Hui KM, Cheang P et al. (2009). Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Stem Cells 27: 1366–1375.

    Article  CAS  Google Scholar 

  • Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249–264.

    Article  Google Scholar 

  • Jarry A, Dorso L, Gratio V, Forgue-Lafitte ME, Laburthe M, Laboisse CL et al. (2007). PAR-2 activation increases human intestinal mucin secretion through EGFR transactivation. Biochem Biophys Res Commun 364: 689–694.

    Article  CAS  Google Scholar 

  • Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A . (2002). The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 4: 540–544.

    Article  CAS  Google Scholar 

  • Kakkar R, Lee RT . (2008). The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7: 827–840.

    Article  CAS  Google Scholar 

  • Kedrin D, Wyckoff J, Boimel PJ, Coniglio SJ, Hynes NE, Arteaga CL et al. (2009). ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasation. Clin Cancer Res 15: 3733–3739.

    Article  CAS  Google Scholar 

  • Klemenz R, Hoffmann S, Werenskiold AK . (1989). Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc Natl Acad Sci USA 86: 5708–5712.

    Article  CAS  Google Scholar 

  • Kustikova O, Kramerov D, Grigorian M, Berezin V, Bock E, Lukanidin E et al. (1998). Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol 18: 7095–7105.

    Article  CAS  Google Scholar 

  • Marone R, Hess D, Dankort D, Muller WJ, Hynes NE, Badache A . (2004). Memo mediates ErbB2-driven cell motility. Nat Cell Biol 6: 515–522.

    Article  CAS  Google Scholar 

  • Marty M, Cognetti F, Maraninchi D, Snyder R, Mauriac L, Tubiana-Hulin M et al. (2005). Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J Clin Oncol 23: 4265–4274.

    Article  CAS  Google Scholar 

  • Mazumdar A, Adam L, Boyd D, Kumar R . (2001). Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion. Cancer Res 61: 400–405.

    CAS  PubMed  Google Scholar 

  • Meisel C, Bonhagen K, Lohning M, Coyle AJ, Gutierrez-Ramos JC, Radbruch A et al. (2001). Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking. J Immunol 166: 3143–3150.

    Article  CAS  Google Scholar 

  • Michl P, Ramjaun AR, Pardo OE, Warne PH, Wagner M, Poulsom R et al. (2005). CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell 7: 521–532.

    Article  CAS  Google Scholar 

  • Morris DR, Ding Y, Ricks TK, Gullapalli A, Wolfe BL, Trejo J . (2006). Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 66: 307–314.

    Article  CAS  Google Scholar 

  • Olayioye MA, Neve RM, Lane HA, Hynes NE . (2000). The ErbB signaling network: receptor heterodimerization in development and cancer. Embo J 19: 3159–3167.

    Article  CAS  Google Scholar 

  • Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S et al. (2001). Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 164: 277–281.

    Article  CAS  Google Scholar 

  • Rossler U, Thomassen E, Hultner L, Baier S, Danescu J, Werenskiold AK . (1995). Secreted and membrane-bound isoforms of T1, an orphan receptor related to IL-1-binding proteins, are differently expressed in vivo. Dev Biol 168: 86–97.

    Article  CAS  Google Scholar 

  • Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT . (2007). IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117: 1538–1549.

    Article  CAS  Google Scholar 

  • Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. (2005). IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479–490.

    Article  CAS  Google Scholar 

  • Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL . (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182.

    Article  CAS  Google Scholar 

  • Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712.

    Article  CAS  Google Scholar 

  • Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A et al. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783–792.

    Article  CAS  Google Scholar 

  • Spencer KS, Graus-Porta D, Leng J, Hynes NE, Klemke RL . (2000). ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. J Cell Biol 148: 385–397.

    Article  CAS  Google Scholar 

  • Su S, Li Y, Luo Y, Sheng Y, Su Y, Padia RN et al. (2009). Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration. Oncogene 28: 3047–3057.

    Article  CAS  Google Scholar 

  • Tajima S, Oshikawa K, Tominaga S, Sugiyama Y . (2003). The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 124: 1206–1214.

    Article  CAS  Google Scholar 

  • Tominaga S . (1989). A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett 258: 301–304.

    Article  CAS  Google Scholar 

  • Tominaga S, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Komatsu N . (1999). Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM. Biochem Biophys Res Commun 264: 14–18.

    Article  CAS  Google Scholar 

  • Vial E, Sahai E, Marshall CJ . (2003). ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4: 67–79.

    Article  CAS  Google Scholar 

  • Werenskiold AK, Hoffmann S, Klemenz R . (1989). Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts. Mol Cell Biol 9: 5207–5214.

    Article  CAS  Google Scholar 

  • Yarden Y, Sliwkowski MX . (2001). Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127–137.

    Article  CAS  Google Scholar 

  • Zaoui K, Honore S, Isnardon D, Braguer D, Badache A . (2008). Memo-RhoA-mDia1 signaling controls microtubules, the actin network, and adhesion site formation in migrating cells. J Cell Biol 183: 401–408.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank R Marone and N Hynes for support in the preliminary phase of the project, M Lopez and A Gonçalves for helpful discussions, and E Tabone and G Clapisson for providing clinical data. This work was supported by Fondation de France, Association pour la Recherche contre le Cancer and Inserm Avenir Program (AB), Ligue Nationale Contre le Cancer—Label Ligue (DB), INCa grant PL-969-017 « Met-Escape » (NB-V) and fellowships from Fondation de France (JG-D and BD) and Association pour la Recherche sur le Cancer (VS).

Author information

Author notes

  1. J Gillibert-Duplantier and B Duthey: These authors contributed equally to this work.

Authors and Affiliations

  1. Inserm U891, Centre de Recherche en Cancérologie de Marseille, Marseille, France

    J Gillibert-Duplantier, B Duthey, D Salaün, P Finetti, F Bertucci, D Birnbaum & A Badache

  2. Institut Paoli-Calmettes, Marseille, France

    J Gillibert-Duplantier, B Duthey, D Salaün, P Finetti, F Bertucci, D Birnbaum & A Badache

  3. Aix-Marseille Université, Marseille, France

    J Gillibert-Duplantier, B Duthey, D Salaün, F Bertucci, D Birnbaum & A Badache

  4. Centre de Recherche en Cancérologie de Lyon, Inserm UMR1052, CNRS UMR5286, Lyon, France

    V Sisirak & N Bendriss-Vermare

  5. Centre Léon Bérard, Lyon, France

    V Sisirak, T Gargi, O Trédan & N Bendriss-Vermare

  6. Université Claude Bernard Lyon 1, Lyon, France

    V Sisirak & N Bendriss-Vermare

Authors
  1. J Gillibert-Duplantier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Duthey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V Sisirak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Salaün
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Gargi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O Trédan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P Finetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F Bertucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D Birnbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. N Bendriss-Vermare
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A Badache
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Badache.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gillibert-Duplantier, J., Duthey, B., Sisirak, V. et al. Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis. Oncogene 31, 3516–3524 (2012). https://doi.org/10.1038/onc.2011.525

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2011.525

Keywords

This article is cited by

Search

Advanced search

Quick links